Barbanti, P., Egeo, G., Aurilia, C., D’Onofrio, F., Albanese, M., Cetta, I., et al. (2022). Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x). THE JOURNAL OF HEADACHE AND PAIN, 23(1) [10.1186/s10194-022-01422-y].
Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x)
Albanese M;
2022-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Correction Friend 231.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
640.47 kB
Formato
Adobe PDF
|
640.47 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
